No more pens and mugs from pharma?

From the New York Times article:

The pens, pads, mugs and other gifts that drug makers have long showered on doctors will be banned from pharmaceutical marketing campaigns under a voluntary guideline that the industry is expected to announce Thursday.

The industry’s Code on Interactions with Health Care Professionals will ask the chief executives of large drug makers to certify in writing that “they have policies and procedures in place to foster compliance with the code.” The code was written by the Pharmaceutical Research and Manufacturers of America, the industry’s trade association.

Wow, this really gets at the real issues (NOT!). Click here to read the article.

A grave problem

From the New York Times article:

“From 2000 to 2007, Medicare paid 478,500 claims containing identification numbers that were assigned to deceased physicians,” the subcommittee said in a new report. “The total amount paid for these claims is estimated to be between $60 million and $92 million. These claims contained identification numbers for an estimated 16,548 to 18,240 deceased physicians.”

Click here to access the NYT article.

Junk food at U.S. public schools

From the Robert Wood Johnson Foundation news release:

The foods and food policies in U.S. public schools become significantly less healthy as students progress from elementary to high school, according to new research published today in Pediatrics. More than 96 percent of high schools have vending machines, and 91 percent of them sell some unhealthy options, while only 17 percent of elementary schools have vending machines on campus. In addition, 93 percent of high schools and 92 percent of middle schools sell foods and beverages a la carte, and nearly 80 percent of these schools offer unhealthy options in their a la carte sales.

Click here to read the entire news release. Click here to access the journal abstract.

Pre-Publication Preview of Joint Commission 2009 Standards

Click here to access.

Wrong side surgery incident

From the Boston Globe article:

An experienced surgeon at Beth Israel Deaconess Medical Center operated on the wrong side of a patient this week, a serious medical mistake disclosed in an e-mail that hospital administrators sent to staff members yesterday.

State authorities are investigating the errant surgery, which happened Monday during an elective procedure. A hospital administrator declined to provide specifics about the operation but said it did not involve removal of organs and did not cause permanent damage to the middle-aged patient, who was expected to suffer short-term discomfort. A state health regulator described the operation as an orthopedic procedure.

Click here to access.

New York Times "The Evidence Gap: A Series"

Encourage y'all to read the first two articles in this NYT series of articles. Click here to access.

Check out this Medical Meetings article

"Pfizer Cuts Off Funding for Medical Education Companies"; click here to read it!

A new trend in pharma support of CME?

From the CNNMoney.com article:

Pfizer Inc. (PFE), hoping to temper criticism that it's improperly influencing doctors, is eliminating direct financial support for medical-education courses that are offered by third-party companies.

The New York drug giant will continue to fund so-called continuing medical education, or CME, courses at academic institutions, teaching hospitals and those supported by medical societies. But it will no longer directly support CME courses offered by for-profit medical-education and communication companies.

Pfizer may continue indirect support for commercial CME companies as well. That's because the academic centers and medical associations that it supports may contract with CME companies, Clary said. "The distinction we're making is we're not directly paying them," she said.

Good news for academia and medical societies. What about the non-academic hospital systems? Click here to read the article. Hat tip to Pharmalot.

New rapid diagnostic test for MDR-TB

From the WHO news release:

People in low-resource countries who are ill with multidrug-resistant TB (MDR-TB) will get a faster diagnosis -- in two days, not the standard two to three months -- and appropriate treatment thanks to two new initiatives unveiled today by WHO, the Stop TB Partnership, UNITAID and the Foundation for Innovative New Diagnostics (FIND).

Click here to read more.

ACCME receives letter from Senate Special Committee on Aging

Click here to access.

Big Bad Pharma?

About 74% of Americans think so, according to a recent Harris Interactive Poll. Click here to access the survey results.

Statehealthfacts.org update

Statehealthfacts.org has recently added new and updated data on Health Status, Health Costs & Budgets, Managed Care and Health Insurance, and Women’s Health. Click here to access.

WHO issues surgical safety checklist and implementation manual

Click here.

Grassley news release regarding conflicted NIH research grant recipients

From the news release:

Senator Chuck Grassley is asking members of Congress who hold leadership positions on the appropriations committee to join his effort to hold the National Institutes of Health accountable for monitoring conflicts of interest in government sponsored medical research.

“There’s mounting evidence that the NIH hasn’t done due diligence in keeping track of industry payments to medical researchers,” Grassley said. “With the objectivity and integrity of research at stake, along with public trust in the system, there are plenty of reasons for Congress to step in to establish penalties for grantees who fail to report financial conflicts and to bring transparency to taxpayer funded medical research.”

Current federal law requires the NIH to monitor financial conflicts of interest by requiring the institutions who receive grants who receive grants to collect and manage information on the money that their researchers receive from drug and device makers and others in industry. Recent reports have revealed that this tracking is not happening in individual cases. In addition, the Inspector General for the Department of Health and Human Services reported in January that the NIH does not adequately monitor its extramural grants for conflicts of interest.

Click here to access.

A bitch with a little gray hair wins!

Kelly is my cousin Lynn's dog, give it watch if you love dogs!

ACCME recent news releases hit the blogs

Check out these two recent blog entries:

"Using ACCME's New Rules for Bias and Profit" courtesy of the Carlat Psychiatry Blog
"ACCME Plans to Bulk Up While Cracking Down...I Think...Until It Will Exist No More" courtesy of the Pathophilia Blog

A girl and her dog

From Britain's Got Talent:

AAMC news release on industry support of CME!

From the news release:

The AAMC (Association of American Medical Colleges) today urged all medical schools and teaching hospitals to adopt policies that prohibit drug industry gifts and services to physicians, faculty, residents, and students, and to limit industry support of continuing medical education activities. The recommendations were part of a new AAMC report, "Industry Funding of Medical Education," unanimously approved by the association's Executive Council. In adopting the report, the AAMC's leadership urged all association members to implement policies and procedures, consistent with the report's guidelines, by July 1, 2009.

The report was the result of a 14-month effort by an AAMC task force, established in 2006, to examine the benefits and pitfalls associated with industry funding of medical education, and to develop principles, recommendations, and guidelines to help medical schools and teaching hospitals better manage their relationships with industry. The panel was chaired by retired Merck Chairman and CEO Roy Vagelos, M.D., and the vice chair was William Danforth, M.D., former chancellor of Washington University. The task force membership included institutional leaders, faculty, residents, students, CEOs from the pharmaceutical, biotechnology, and medical device industries, ethicists, and public representatives.

"Interactions between industry and academic medicine are vital to public health," said AAMC President and CEO Darrell G. Kirch, M.D. "But they must be principled partnerships effectively managed to sustain public trust in both partners' commitment to patient welfare and the improvement of health care. The recommendations outlined in this report provide essential guidance for how medical schools and teaching hospitals can achieve this important goal."

Click here to access.

Experimercial?

Giovanni A. Fava, Professor of Clinical Psychology at the University of Bologna, Itay, makes some strong statements in an opinion piece "Should the drug industry work with key opinion leaders? No" just published in the British Medical Journal.

It's definitely worth a read, as is "Should the drug industry work with key opinion leaders. Yes" written by Charlies Buckwell, CEO, Complete Medical Group.

Click here to access (sub. req.).

Doctor Radio?

Yep! Sirius Satellite Radio has launched "Doctor Radio" which features real doctors responding to callers' questions. Click here to find out more.